CAS RN: 1116571-01-7

1-PiperazinecarboxiMidaMide, N’-(3-broMophenyl)-N-cyano-2-Methyl-4-(5-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)-, (2S)-

Product Availability

Choose a grade to view its available package options.

6 package records4 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250317 100mg In stock Shanghai Inquiry
Batchno.20250216 100mg / 250mg Out of stock 5-7 business days Inquiry
Batchno.20250614 1g Out of stock Inquiry
Batchno.20250302 250mg In stock Shanghai Inquiry
Batchno.20250202 25mg In stock Shanghai Inquiry
Batchno.20250706 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1116571-01-7
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1116571-01-7 / (2S)-N'-(3-bromophenyl)-N-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide

Lim kinase 2 inhibitor | LIMK-IN-22j | LIMK-IN-1

Standard CAS: 1116571-01-7 Multi CAS: Yes

Basic Information

CAS
1116571-01-7
Multi CAS
Yes
Molecular Formula
C20H21BrN8
Molecular Weight
453.300000
Exact Mass
452.107260
SMILES
C[C@H]1CN(CCN1C(=NC2=CC(=CC=C2)Br)NC#N)C3=NC=NC4=C3C(=CN4)C
InChI
InChI=1S/C20H21BrN8/c1-13-9-23-18-17(13)19(26-12-25-18)28-6-7-29(14(2)10-28)20(24-11-22)27-16-5-3-4-15(21)8-16/h3-5,8-9,12,14H,6-7,10H2,1-2H3,(H,24,27)(H,23,25,26)/t14-/m0/s1
InChIKey
KSECQYDNQYAZMQ-AWEZNQCLSA-N
Synonyms
Lim kinase 2 inhibitor LIMK-IN-22j LIMK-IN-1 (S)-N-(3-bromophenyl)-N'-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboximidamide CHEMBL570126

Computed Properties

Structural Parameters

Heavy atom count
29
Aromatic heavy atom count
15
Fraction Csp3
0.3
Rotatable bonds
2
H-bond acceptors
5
H-bond donors
2
Molar refractivity
116.99
TPSA
96.23

LogP / Solubility

WLOGP
3.3
MLOGP
2.93
XLogP3
3.6
Consensus LogP
3.28
Log S (ESOL)
-4.98
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.66
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.58
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.14

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3.5

Get In Touch

Contact Us